Financial Press Releases

CohBar, Inc. Announces First Quarter 2017 Financial Results

Menlo Park, California - May 15, 2017 - CohBar, Inc. (OTCQX: CWBR and TSXV: COB.U), a preclinical stage biotechnology company focused on developing mitochondria based therapeutics (MBTs) to treat age-related diseases, today reported financial results for the first quarter ended March 31, 2017. read-more

CohBar, Inc. Announces Fourth Quarter 2016 Financial Results

Menlo Park, California – March 22, 2017 – CohBar, Inc. (OTCQX: CWBR and TSXV: COB.U), a preclinical stage biotechnology company focused on developing mitochondria based therapeutics (MBTs) to treat age-related diseases, today reported financial results for the fourth quarter ended December 31, 2016 and provided an update on the Company’s preclinical development program. read-more

CohBar, Inc. to Announce Fourth Quarter 2016 Financial Results and Host Conference Call for Shareholders on March 22, 2017

Menlo Park, California – March 3, 2017 – CohBar, Inc. (OTCQX: CWBR and TSXV: COB.U), a preclinical stage biotechnology company focused on developing mitochondria based therapeutics (MBTs) to treat age-related diseases, announced today that the Company will release its fourth quarter 2016 financial results on Wednesday, March 22, 2017 and management will host a conference call for shareholders the same day at 2:00 p.m. (PST). read-more

CohBar, Inc. Announces Expiration of Warrants and Reports Aggregate Proceeds from Warrant Exercises

Menlo Park, California – January 11, 2017 - CohBar, Inc. (OTCQX: CWBR and TSXV: COB.U), a preclinical stage biotechnology company focused on developing mitochondria based therapeutics (MBTs) to treat age-related diseases, announced today that a total of approximately 2.7 million of the outstanding warrants to purchase CohBar’s common stock were exercised prior to their expiration at 5:00 p.m. EST on January 6, 2017. As a result of the warrant exercises, the Company received total gross proceeds of approximately $5.3 million and issued a total of 2,672,478 common shares. read-more

CohBar, Inc. Announces Third Quarter 2016 Financial Results

Menlo Park, California – November 14, 2016 - CohBar, Inc. (OTCQX: CWBR and TSXV: COB.U), an innovative biotechnology company focused on developing mitochondria based therapeutics (MBTs) to treat diseases associated with aging and increase healthy lifespan, today reported financial results for the third quarter ended September 30, 2016. read-more

CohBar, Inc. Announces Second Quarter 2016 Financial Results

Menlo Park, California – August 15, 2016 - CohBar, Inc. (OTCQX: CWBR and TSXV: COB.U), an innovative biotechnology company focused on developing mitochondria-based therapeutics (MBTs) to treat diseases associated with aging, today reported financial results for the second quarter ended June 30, 2016. read-more

CohBar, Inc. Announces First Quarter 2016 Financial Results

Menlo Park, California – May 13, 2016 - CohBar, Inc. (OTCQX: CWBR and TSXV: COB.U), an innovative biotechnology company focused on developing mitochondria-based therapeutics (MBTs) to treat diseases associated with aging, today reported financial results for the first quarter ended March 31, 2016. read-more

CohBar, Inc. Announces Fourth Quarter 2015 Financial Results

Menlo Park, California – March 9, 2016 - CohBar, Inc. (OTCQX: CWBR and TSXV: COB.U), an innovative biotechnology company focused on developing mitochondria-based therapeutics (MBTs) to treat diseases associated with aging, today reported financial results for the fourth quarter ended December 31, 2015. read-more

CohBar, Inc. to Announce 2015 Fourth Quarter Financial Results and Host Conference Call for Shareholders on March 9, 2016

Menlo Park, California – February 24, 2016 - CohBar, Inc. (OTCQX: CWBR and TSXV: COB.U), an innovative biotechnology company focused on developing mitochondria-based therapeutics (MBTs) to treat diseases associated with aging, will release its 2015 fourth quarter financial results on Wednesday, March 9, 2016, and will host a call for shareholders the same day at 2:00 p.m. (PST). read-more

CohBar, Inc. Announces Third Quarter 2015 Financial Results

Menlo Park, California – November 16, 2015 – CohBar, Inc. (OTCQX: CWBR and TSX-V: COB.U), an innovative biotechnology company focused on developing mitochondria-based therapeutics (MBTs) to treat diseases associated with aging, today reported financial results for the three months ended September 30, 2015. read-more

CohBar, Inc. To Announce 2015 Third Quarter Financial Results and Host Conference Call for Shareholders on November 16, 2015

Menlo Park, California – November 11, 2015 – CohBar, Inc. (OTCQX: CWBR and TSX-V: COB.U), an innovative biotechnology company focused on developing mitochondria-based therapeutics (MBTs) to treat diseases associated with aging, will release its 2015 third quarter financial results on Monday, November 16, 2015, and  will host a call for shareholders the same day at 2:00 p.m. (PDT). read-more

CohBar, Inc. Announces Second Quarter 2015 Financial Results

Menlo Park, California – August 11, 2015 – CohBar, Inc. (OTCQX: CWBR and TSX-V: COB.U), an innovative biotechnology company focused on developing mitochondria-based therapeutics (MBTs) to treat diseases associated with aging, today reported financial results for the three months ended June 30, 2015. read-more

CohBar, Inc. Announces First Quarter 2015 Financial Results

Menlo Park, California – May 15, 2015 – CohBar, Inc. (TSX-V: COB.U), an innovative biotechnology company focused on developing mitochondria-based therapeutics to treat diseases associated with aging, today reported financial results for the three months ended March 31, 2015. read-more

CohBar, Inc. Announces Full Year 2014 Financial Results

Menlo Park, California  – March 31, 2015 – CohBar, Inc. (TSX-V: COB.U), an innovative biotechnology company focused on developing mitochondria-based therapeutics to treat diseases associated with aging, today provided a corporate update and reported financial results for the full year ending December 31, 2014. read-more

CohBar, Inc. Completes US$11.25M IPO to Discover and Develop Novel Mitochondrial-derived Therapeutics

Pasadena, California - January 8, 2015 - CohBar, Inc. (TSX-V: COB.U), an innovative biotechnology company focused on discovering mitochondrial-derived peptides (MDPs) and developing them into novel therapeutics to treat major diseases and extend healthy life spans, today announced that it has met the requirements to begin trading on the TSX Venture Exchange. CohBar will commence active trading on January 8, 2015, under ticker symbol COB.U. CohBar has also registered with the U.S. Securities and Exchange Commission and will report as a U.S. public company. Read read-more